Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
17.35
+0.32 (1.88%)
At close: Oct 13, 2025, 4:00 PM EDT
17.35
0.00 (0.00%)
After-hours: Oct 13, 2025, 5:37 PM EDT
Immunovant Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$30.57
Upside
+76.20%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JP Morgan | JP Morgan | Buy Maintains $37 → $33 | Buy | Maintains | $37 → $33 | +90.20% | Sep 30, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +101.73% | Sep 4, 2025 |
JP Morgan | JP Morgan | Buy Maintains $40 → $37 | Buy | Maintains | $40 → $37 | +113.26% | Aug 12, 2025 |
B of A Securities | B of A Securities | Strong Buy Maintains $33 → $30 | Strong Buy | Maintains | $33 → $30 | +72.91% | Aug 12, 2025 |
UBS | UBS | Hold Maintains $17 → $18 | Hold | Maintains | $17 → $18 | +3.75% | Jul 28, 2025 |
UBS | UBS | Strong Buy → Hold Downgrades $38 → $17 | Strong Buy → Hold | Downgrades | $38 → $17 | -2.02% | Apr 22, 2025 |
Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Mar 20, 2025 |
B of A Securities | B of A Securities | Strong Buy Maintains $38 → $33 | Strong Buy | Maintains | $38 → $33 | +90.20% | Mar 20, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +193.95% | Mar 19, 2025 |
Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Mar 10, 2025 |
Guggenheim | Guggenheim | Strong Buy Maintains $46 → $44 | Strong Buy | Maintains | $46 → $44 | +153.60% | Feb 10, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +193.95% | Feb 10, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +193.95% | Feb 7, 2025 |
B of A Securities | B of A Securities | Strong Buy Maintains $48 → $45 | Strong Buy | Maintains | $48 → $45 | +159.37% | Jan 15, 2025 |
Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 3, 2025 |
Wells Fargo | Wells Fargo | Buy Maintains $47 → $45 | Buy | Maintains | $47 → $45 | +159.37% | Dec 19, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.